{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T22:24:01Z","timestamp":1743978241847},"reference-count":163,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1317,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1111\/j.1365-2133.2011.10767.x","type":"journal-article","created":{"date-parts":[[2012,1,23]],"date-time":"2012-01-23T14:10:31Z","timestamp":1327327831000},"page":"252-260","source":"Crossref","is-referenced-by-count":5,"title":["Psoriasis: an evidence-based update. Report of the 9th Evidenced Based Update Meeting, 12 May 2011, Loughborough, U.K."],"prefix":"10.1093","volume":"166","author":[{"given":"P.","family":"De Mozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.A.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.B.","family":"Alexandroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,1,23]]},"reference":[{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB1|cit1","first-page":"CD005028","article-title":"Topical treatments for chronic plaque psoriasis","volume":"2","author":"Mason","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1365-2133.1998.02032.x","article-title":"Comparison of phototherapy with near vs. far erythemogenic doses of narrow-band ultraviolet B in patients with psoriasis","volume":"138","author":"Hofer","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2133.2011.10396.x","article-title":"Efficacy of PUVA therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry","volume":"165","author":"Inzinger","year":"2011","journal-title":"Br J Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2011.10767.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2009.03389.x","article-title":"European S3-guidelines on the systemic treatment of psoriasis vulgaris","volume":"23","author":"Pathirana","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2008.08926.x","article-title":"Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept","volume":"160","author":"Wolf","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1468-3083.2005.01247.x","article-title":"An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis","volume":"19","author":"Ortonne","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archderm.143.8.1016","article-title":"Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis","volume":"143","author":"Legat","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB8|cit8","first-page":"245","article-title":"Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes","volume":"7","author":"Kircik","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB9|cit9","first-page":"S48","article-title":"UVB-311\u2003nm advances the clearance of psoriatic lesions in ustekinumab-treated patients","volume":"130","author":"Weger","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-0781.2011.00594.x","article-title":"311\u2003nm UVB accelerated response of psoriatic lesions in adalimumab-treated patients","volume":"27","author":"Wolf","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000204715","article-title":"A short cycle of narrow-band UVB phototherapy in the early phase of long-term efalizumab can provide a quicker remission of moderate and severe psoriasis: a pilot study","volume":"218","author":"Zane","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1365-2133.2011.10358.x","article-title":"Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6\u2003weeks","volume":"164","author":"Gambichler","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1365-2133.2010.09663.x","article-title":"Is antitumour necrosis factor therapy combined with ultraviolet B phototherapy safe?","volume":"162","author":"Di Lernia","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2133.2006.07725.x","article-title":"Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet","volume":"156","author":"Michaelsson","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2005.07.024","article-title":"The psoriasis variant palmoplantar pustulosis can be improved after cessation of smoking","volume":"54","author":"Michaelsson","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2006.07582.x","article-title":"Moral and cost dilemma of a psoriasis patient","volume":"156","author":"Abdul","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/00016488309121152","article-title":"Evaluation of tonsillectomy as a treatment for pustulosis palmaris et plantaris","volume":"401","author":"Ono","year":"1983","journal-title":"Acta Otolaryngol Suppl"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1346-8138.1977.tb01033.x","article-title":"Evaluation of tonsillectomy as a treatment for pustulosis palmaris et plantaris","volume":"4","author":"Ono","year":"1977","journal-title":"J Dermatol"},{"issue":"Suppl. 17","key":"10.1111\/j.1365-2133.2011.10767.x-BIB19|cit19","first-page":"13","article-title":"Photochemotherapy for persistent palmoplantar pustulosis (PPP)","volume":"101","author":"Murray","year":"1979","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2133.1980.tb06565.x","article-title":"A controlled trial of photochemotherapy for persistent palmoplantar pustulosis","volume":"102","author":"Murray","year":"1980","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2133.1984.tb07471.x","article-title":"A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis","volume":"110","author":"Lawrence","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2133.1985.tb02320.x","article-title":"The effect of etretinate compared with different regimens of PUVA in the treatment of persistent palmoplantar pustulosis","volume":"112","author":"Lassus","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0190-9622(08)80228-9","article-title":"Fumaric acid therapy in psoriasis: results and side effects of 2\u2003years of treatment","volume":"27","author":"Kolbach","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0190-9622(94)70121-0","article-title":"Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients","volume":"30","author":"Altmeyer","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000247856","article-title":"Fumaric acid therapy in psoriasis: a double-blind comparison between fumaric acid compound therapy and monotherapy with dimethylfumaric acid ester","volume":"181","author":"Nieboer","year":"1990","journal-title":"Dermatologica"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1365-2133.2003.05424.x","article-title":"Efficacy of fumaric acid ester monotherapy in psoriasis pustulosa palmoplantaris","volume":"149","author":"Stander","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1365-2133.2010.09897.x","article-title":"Ustekinumab in the treatment of palmoplantar pustulosis","volume":"163","author":"Gerdes","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1365-2133.2011.10233.x","article-title":"Management of palmoplantar pustulosis: do we need to change?","volume":"164","author":"Mrowietz","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB29|cit29","unstructured":"de Vries ACQ Bogaards NA Hooft L et\u00a0al Interventions for nail psoriasis: a Cochrane review 20th European Academy of Dermatology and Venereology Congress"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000246274","article-title":"Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1728 patients","volume":"193","author":"de Jong","year":"1996","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2133.2010.09831.x","article-title":"Nail psoriasis in Germany: epidemiology and burden of disease","volume":"163","author":"Augustin","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jaad.2007.07.042","article-title":"Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1\u2003year","volume":"58","author":"Rich","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/art.24403","article-title":"Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four-week efficacy and safety results of a randomized, placebo-controlled study","volume":"60","author":"Kavanaugh","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2340\/0001555572134136","article-title":"A double-blind study of superficial radiotherapy in psoriatic nail dystrophy","volume":"72","author":"Yu","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000068469","article-title":"Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study","volume":"206","author":"Cannavo","year":"2003","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000018281","article-title":"Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study","volume":"199","author":"de Jong","year":"1999","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2340\/00015555-0195","article-title":"Treatment of psoriatic nails with tazarotene cream 0\u00b71% vs. clobetasol propionate 0\u00b705% cream: a double-blind study","volume":"87","author":"Rigopoulos","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB38|cit38","first-page":"279","article-title":"Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis","volume":"88","author":"Tzung","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2340\/000155557590","article-title":"A therapeutic study of nail psoriasis using electron beams","volume":"75","author":"Kwang","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2340\/00015555756569","article-title":"Remission of ordinary psoriasis following a short clearance course of cyclosporin","volume":"75","author":"Levell","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0190-9622(95)90189-2","article-title":"Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement","volume":"32","author":"Mahrle","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/jid.2008.233","article-title":"Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis","volume":"129","author":"Huffmeier","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa062382","article-title":"A human interleukin-12\/23 monoclonal antibody for the treatment of psoriasis","volume":"356","author":"Krueger","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2133.2009.09505.x","article-title":"British Association of Dermatologists\u2019 guidelines for biologic interventions for psoriasis 2009","volume":"161","author":"Smith","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa0810652","article-title":"Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis","volume":"362","author":"Griffiths","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1365-2133.2009.09238.x","article-title":"Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept","volume":"161","author":"Ortonne","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jaad.2006.05.027","article-title":"Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study","volume":"55","author":"Gordon","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199503023320907","article-title":"Treatment of psoriasis","volume":"332","author":"Greaves","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2133.2009.09498.x","article-title":"Daily practice assessment of liver injury in patients with psoriasis on methotrexate","volume":"162","author":"Driessen","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MCG.0b013e31817f9367","article-title":"Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn\u2019s disease before and after delivery","volume":"43","author":"Kane","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment","volume":"60","author":"British Thoracic Society Standards of Care Committee","year":"2005","journal-title":"Thorax"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2230.2007.02531.x","article-title":"Twenty-one years of oral retinoid therapy in siblings with nonbullous ichthyosiform erythroderma","volume":"33","author":"Macbeth","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1365-2133.2010.09755.x","article-title":"British Association of Dermatologists\u2019 guidelines on the efficacy and use of acitretin in dermatology","volume":"162","author":"Ormerod","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2133.2008.09005.x","article-title":"New-onset psoriasis in a patient treated with interferon beta-1a","volume":"160","author":"Lopez-Lerma","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2133.2009.09563.x","article-title":"Antinuclear antibodies associate with loss of response to antitumour necrosis factor-alpha therapy in psoriasis: a retrospective, observational study","volume":"162","author":"Pink","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/eurheartj\/ehp567","article-title":"Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database","volume":"31","author":"Mehta","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB62|cit62","first-page":"103","volume-title":"Advances in Medicine and Biology","volume":"6","author":"Alexandroff","year":"2011"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-2133.2008.09020.x","article-title":"Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis","volume":"160","author":"Brauchli","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2230.2010.03893.x","article-title":"Atherosclerosis as a systemic feature of psoriasis","volume":"36","author":"Alexandroff","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2133.2009.09372.x","article-title":"Psoriasis: an opportunity to identify cardiovascular risk","volume":"161","author":"Tobin","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2008.08874.x","article-title":"Psoriasis: an opportunity to identify cardiovascular risk","volume":"160","author":"Federman","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","article-title":"Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K","volume":"163","author":"Abuabara","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaad.2004.06.017","article-title":"Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis","volume":"52","author":"Prodanovich","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","article-title":"The risk of mortality in patients with psoriasis: results from a population-based study","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2009.09281.x","article-title":"More than skin deep: atherosclerosis as a systemic manifestation of psoriasis","volume":"161","author":"Alexandroff","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB71|cit71","first-page":"77","article-title":"Psoriasis and psoriatic arthritis: association with other inflammatory diseases and comorbidities","volume":"2","author":"Alexandroff","year":"2011","journal-title":"Adv Psor Inflamm Skin Dis"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1365-2133.2011.10271.x","article-title":"Psoriasis and melanocytic naevi: does the first confer a protective role against melanocyte progression to naevi?","volume":"164","author":"Balato","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1365-2133.2011.10355.x","article-title":"Drug survival rates for tumour necrosis factor-alpha antagonists in psoriasis","volume":"164","author":"Burden","year":"2011","journal-title":"Br J Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2133.2011.10767.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2011.10280.x","article-title":"Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course","volume":"164","author":"Warren","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1365-2133.2011.10345.x","article-title":"Alcohol misuse in patients with psoriasis: identification and relationship to disease severity and psychological distress","volume":"164","author":"McAleer","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2133.2011.10294.x","article-title":"Review of the 90th Annual Meeting of the British Association of Dermatologists, 6-8 July 2010, Manchester, U.K","volume":"164","author":"Prasad Hunasehally","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2230.2008.03026.x","article-title":"Serum levels of transforming growth factor-beta1 in patients with mild psoriasis vulgaris and effect of treatment with biological drugs","volume":"34","author":"Kallimanis","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1365-2133.2010.09995.x","article-title":"Ustekinumab: effective in a patient with severe recalcitrant generalized pustular psoriasis","volume":"163","author":"Dauden","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2133.2010.09925.x","article-title":"Management of psoriasis in pregnancy: time to deliver?","volume":"163","author":"Griffiths","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1365-2133.2010.09944.x","article-title":"A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis","volume":"163","author":"Fonia","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2133.2010.09950.x","article-title":"Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept","volume":"163","author":"van Lumig","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2133.2010.09870.x","article-title":"Therapeutic ultraviolet light-emitting diode sources: a new phase in the evolution of phototherapy","volume":"163","author":"Edwards","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1365-2133.2010.09935.x","article-title":"The role of endothelial cell apoptosis in the effect of etanercept in psoriasis","volume":"163","author":"Avramidis","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1365-2133.2010.09938.x","article-title":"Primary varicella-zoster infection in patients on biologic therapies for psoriasis","volume":"163","author":"Hackett","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB85|cit85","first-page":"162","article-title":"Skin deep: report from the annual meeting of the British Society for Investigative Dermatology","volume":"29","author":"Alexandroff","year":"2007","journal-title":"Exp Oncol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1365-2133.2010.09916.x","article-title":"Self-management experiences in adults with mild-moderate psoriasis: an exploratory study and implications for improved support","volume":"163","author":"Ersser","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2133.2010.09917.x","article-title":"Expression of human leucocyte antigen-G primarily targets affected skin of patients with psoriasis","volume":"163","author":"Cardili","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2133.2009.09107.x","article-title":"Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology","volume":"160","author":"Alexandroff","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2010.09907.x","article-title":"Is serum amyloid A protein a better indicator of inflammation in severe psoriasis?","volume":"163","author":"Dogan","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-2133.2010.09893.x","article-title":"Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study","volume":"163","author":"Woolf","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2133.2010.09899.x","article-title":"Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis","volume":"163","author":"Bandoli","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2133.2010.09832.x","article-title":"Observational case series on a group of patients with severe psoriasis who failed to respond to antitumour necrosis factor alpha biologics and switched to ustekinumab","volume":"163","author":"Downs","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2133.2009.09395.x","article-title":"Report from the 67th Annual Meeting of American Academy of Dermatology","volume":"162","author":"Alexandroff","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2133.2010.09819.x","article-title":"Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis","volume":"163","author":"Hagforsen","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1365-2133.2010.09707.x","article-title":"Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis","volume":"162","author":"Langley","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2133.2010.09790.x","article-title":"Decreased colony formation of high proliferative potential colony-forming cells and granulocyte-macrophage colony-forming units and increased Hes-1 expression in bone marrow mononuclear cells from patients with psoriasis","volume":"163","author":"Zhang","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2133.2010.09791.x","article-title":"A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol\/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study","volume":"163","author":"Thaci","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2133.2009.09624.x","article-title":"Fumaric acid esters in the treatment of psoriasis","volume":"162","author":"Anstey","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3399\/bjgp10X483364","article-title":"The patient\u2019s journey: living with psoriasis - the doctors\u2019 perspective","volume":"60","author":"Alexandroff","year":"2010","journal-title":"Br J Gen Pract"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1365-2133.2010.09706.x","article-title":"Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement","volume":"162","author":"Soegaard-Madsen","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2133.2010.09766.x","article-title":"Arginase is overactive in psoriatic skin","volume":"163","author":"Abeyakirthi","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2133.2010.09767.x","article-title":"Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis","volume":"163","author":"Vahavihu","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1365-2133.2010.09758.x","article-title":"High-concentration (20\u2003\u03bcg g\u22121) tacalcitol ointment in the treatment of facial psoriasis: an 8-week open-label clinical trial","volume":"162","author":"Choi","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1365-2133.2010.09760.x","article-title":"Topical calcitriol restores the impairment of epidermal permeability and antimicrobial barriers induced by corticosteroids","volume":"162","author":"Hong","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2133.2010.09763.x","article-title":"Targeted phototherapy of plaque-type psoriasis using ultraviolet B-light-emitting diodes","volume":"163","author":"Kemeny","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2133.2010.09742.x","article-title":"Foxp3+\u2003 regulatory T cells and related cytokines differentially expressed in plaque vs. guttate psoriasis vulgaris","volume":"163","author":"Yan","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1365-2133.2010.09669.x","article-title":"Ustekinumab induces rapid clearing of erythrodermic psoriasis after failure of antitumour necrosis factor therapies","volume":"162","author":"Santos-Juanes","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2010.09650.x","article-title":"Infliximab therapy induces increased polyclonality of CD4+\u2003CD25+\u2003regulatory T cells in psoriasis","volume":"162","author":"Diluvio","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2010.09737.x","article-title":"Psoriasis and extra domain A fibronectin loops","volume":"163","author":"McFadden","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1365-2133.2010.09714.x","article-title":"Safety of antitumour necrosis factor-alpha therapy in psoriatic patients with hepatitis B virus infection","volume":"162","author":"Nosotti","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-2133.2010.09692.x","article-title":"1,24-Dihydroxyvitamin D (tacalcitol) prevents skin T-cell infiltration","volume":"162","author":"Yamanaka","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/j.1365-2133.2010.09693.x","article-title":"The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologics","volume":"162","author":"Driessen","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1365-2133.2010.09662.x","article-title":"Interleukin-1 from epithelial cells fosters T cell-dependent skin inflammation","volume":"162","author":"Renne","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1365-2133.2009.09394.x","article-title":"Comparing narrowband ultraviolet B treatment regimens for psoriasis","volume":"161","author":"Dawe","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1365-2133.2009.09499.x","article-title":"The relevance of biologics for the treatment of patients with psoriasis","volume":"161","author":"van de Kerkhof","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2009.09593.x","article-title":"Epidemiology and comorbidity of psoriasis in children","volume":"162","author":"Augustin","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2133.2009.09595.x","article-title":"Psoriasis and alcohol: is cutaneous ethanol one of the missing links?","volume":"162","author":"Farkas","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2133.2009.09555.x","article-title":"Using \u2018number needed to treat\u2019 to express the magnitudes of benefit of ultraviolet B phototherapy and of antitumour necrosis factor-alpha therapies for psoriasis","volume":"162","author":"Dawe","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2133.2009.09589.x","article-title":"Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis","volume":"162","author":"Dommasch","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1365-2133.2009.09578.x","article-title":"Infliximab for the treatment of psoriasis in Greece: 4\u2003years of clinical experience at a single centre","volume":"162","author":"Antoniou","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2133.2009.09491.x","article-title":"Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial","volume":"162","author":"Lebwohl","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2133.2009.09547.x","article-title":"Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis","volume":"162","author":"Kamsteeg","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2133.2009.09515.x","article-title":"Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: update of the EDEN Psoriasis Survey 2001-2006","volume":"162","author":"Naldi","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1365-2133.2009.09398.x","article-title":"Coeliac disease associated with psoriasis","volume":"161","author":"Birkenfeld","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1365-2133.2009.09464.x","article-title":"Socioeconomic disability in psoriasis","volume":"161","author":"Seidler","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-2133.2009.09329.x","article-title":"Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments","volume":"161","author":"Seneschal","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1365-2133.2009.09348.x","article-title":"Generalized pustular psoriasis induced by systemic glucocorticosteroids: four cases and recommendations for treatment","volume":"161","author":"Brenner","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB128|cit128","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1365-2133.2009.09384.x","article-title":"Experience with biologics for psoriasis in daily practice: switching is worth a try","volume":"161","author":"Lecluse","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1365-2133.2009.09303.x","article-title":"The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin","volume":"161","author":"Kjellerup","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2133.2009.09331.x","article-title":"Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test","volume":"161","author":"Laffitte","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1365-2133.2009.09314.x","article-title":"Inverse relationship between contact allergy and psoriasis: results from a patient- and a population-based study","volume":"161","author":"Bangsgaard","year":"2009","journal-title":"Br J Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2011.10767.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2009.09173.x","article-title":"Alice, Eloi, Magali and Robert: the lives of four patients with psoriasis and the therapeutic approaches of eight European experts","volume":"161","author":"Dubertret","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB133|cit133","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1365-2133.2009.09344.x","article-title":"Immunohistochemical expression of cyclin-dependent kinase-2 in psoriasis","volume":"161","author":"Santos-Briz","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB134|cit134","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2133.2009.09361.x","article-title":"Psoriasis and streptococci: postscript regarding extra domain A fibronectin","volume":"161","author":"McFadden","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB135|cit135","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1365-2133.2009.09247.x","article-title":"Development and pilot-testing of a psoriasis screening tool","volume":"161","author":"Dominguez","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB136|cit136","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2133.2009.09236.x","article-title":"Itch and scratching as predictors of time to clearance of psoriasis with narrow-band ultraviolet B therapy","volume":"161","author":"Evers","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB137|cit137","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2133.2009.09267.x","article-title":"Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study","volume":"162","author":"Wain","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB138|cit138","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2133.2009.09276.x","article-title":"Overweight and childhood psoriasis","volume":"161","author":"Boccardi","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB139|cit139","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1365-2133.2009.09105.x","article-title":"\u2018Real decisions\u2019 on psoriasis care from informed clinicians","volume":"160","author":"Anstey","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB140|cit140","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1365-2133.2009.09212.x","article-title":"Narrowband ultraviolet B therapy in psoriasis: randomized double-blind comparison of high-dose and low-dose irradiation regimens","volume":"161","author":"Kleinpenning","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB141|cit141","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2133.2009.09223.x","article-title":"Delayed generalized inflammatory psoriasis flare during efalizumab treatment","volume":"161","author":"Martin","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB142|cit142","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2133.2009.09156.x","article-title":"The cystatin M\/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis","volume":"161","author":"Cheng","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB143|cit143","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2133.2009.09158.x","article-title":"Using \u2018number needed to treat\u2019 to help conceptualize the magnitude of benefit and risk of tumour necrosis factor-alpha inhibitors for patients with severe psoriasis","volume":"161","author":"Dharamsi","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB144|cit144","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2133.2009.09178.x","article-title":"Upregulation of Fas and downregulation of CD94\/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis","volume":"161","author":"Son","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB145|cit145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2133.2009.09194.x","article-title":"Individual differences in the effect of daily stressors on psoriasis: a prospective study","volume":"161","author":"Verhoeven","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB146|cit146","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2133.2009.09116.x","article-title":"Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial","volume":"161","author":"Kragballe","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB147|cit147","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1365-2133.2009.09115.x","article-title":"Patient preferences and satisfaction with systemic therapies for psoriasis: an area to be explored","volume":"160","author":"Lecluse","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB148|cit148","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-2133.2009.09102.x","article-title":"Psoriasis and streptococci: the natural selection of psoriasis revisited","volume":"160","author":"McFadden","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB149|cit149","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2009.09030.x","article-title":"Plaque thickness and morphology in psoriasis vulgaris associated with therapeutic response","volume":"160","author":"Rakkhit","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB150|cit150","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1365-2133.2008.09013.x","article-title":"Immunological effects of stress in psoriasis","volume":"160","author":"Schmid-Ott","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB151|cit151","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1365-2133.2008.09019.x","article-title":"Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome","volume":"160","author":"Driessen","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB152|cit152","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2133.2008.09012.x","article-title":"Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells","volume":"160","author":"Smits","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB153|cit153","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1365-2133.2008.08962.x","article-title":"Economic evaluation of systemic therapies for moderate to severe psoriasis","volume":"160","author":"Sizto","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB154|cit154","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2133.2008.08987.x","article-title":"Care of patients with psoriasis: an audit of U.K. services in secondary care","volume":"160","author":"Eedy","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB155|cit155","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2133.2008.08961.x","article-title":"Autoantibodies against type XVII collagen C-terminal domain in a patient with bullous pemphigoid associated with psoriasis vulgaris","volume":"160","author":"Inokuma","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB156|cit156","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2133.2008.08972.x","article-title":"Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis","volume":"160","author":"Gerdes","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB157|cit157","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2008.08927.x","article-title":"A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial","volume":"160","author":"van de Kerkhof","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB158|cit158","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2133.2008.08902.x","article-title":"Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin","volume":"160","author":"Johansen","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB159|cit159","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2133.2008.08904.x","article-title":"Detection of psoriasin\/S100A7 in the sera of patients with psoriasis","volume":"160","author":"Anderson","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB160|cit160","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2133.2008.08898.x","article-title":"Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms","volume":"160","author":"Warren","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB161|cit161","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2008.08891.x","article-title":"Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians","volume":"160","author":"Perlmutter","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB162|cit162","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2133.2008.08889.x","article-title":"Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis","volume":"160","author":"Henno","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10767.x-BIB163|cit163","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2133.2008.08890.x","article-title":"Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model","volume":"160","author":"Stenderup","year":"2009","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10767.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2011.10767.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T09:06:14Z","timestamp":1713431174000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/166\/2\/252\/6613755"}},"subtitle":["Report of the 9th Evidence Based Update Meeting on psoriasis"],"short-title":[],"issued":{"date-parts":[[2012,1,23]]},"references-count":163,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10767.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1,23]]}}}